ERAS-4001 — Topline data
H2 2026
We anticipate a Phase 1 monotherapy data readout from the BOREALIS-1 trial in the second half of 2026.Source filing
ERASCA INC · Data as of 2026-09-08
H2 2026
We anticipate a Phase 1 monotherapy data readout from the BOREALIS-1 trial in the second half of 2026.Source filing
H1 2027
Additional ERAS-0015 monotherapy and combination data expected in H1 2027; ERAS-4001 Phase 1 preliminary monotherapy data expected in H2 2026Source filing